おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
MetaHeps
About
MetaHeps provides solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Consulting,Health Care
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
MetaHeps GmbH provides consulting and solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing. It is a unique service provider that generates a personalized cell model reflecting individual drug hepatotoxicity from a small patient blood sample. Customers are research driven pharmaceutical companies and global acting CROs, using Metaheps’ services in clinical phases of drug development as well as postmarketing to diagnose or exclude Druginduced liver injury (DILI) in individual patients.MetaHeps vision is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2017 | Grant | — | 1 |
Bavarian Ministry of Economic Affairs, Energy and Technology
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bavarian Ministry of Economic Affairs, Energy and Technology
|
Yes | Grant |
